View ValuationSun Rise E&T 将来の成長Future 基準チェック /06現在、 Sun Rise E&Tの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長52.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesBuy Or Sell Opportunity • May 04Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to NT$20.60. The fair value is estimated to be NT$26.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Meanwhile, the company became loss making.Buy Or Sell Opportunity • Apr 15Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 40% to NT$20.90. The fair value is estimated to be NT$26.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Apr 09Full year 2025 earnings released: NT$1.97 loss per share (vs NT$4.39 profit in FY 2024)Full year 2025 results: NT$1.97 loss per share (down from NT$4.39 profit in FY 2024). Revenue: NT$471.3m (down 60% from FY 2024). Net loss: NT$80.0m (down 145% from profit in FY 2024). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.お知らせ • Mar 23Sun Rise E&T Corporation, Annual General Meeting, Jun 17, 2026Sun Rise E&T Corporation, Annual General Meeting, Jun 17, 2026. Location: no,2, huan tung st. ta chou li, pingtung city TaiwanBuy Or Sell Opportunity • Mar 02Now 30% overvaluedOver the last 90 days, the stock has fallen 8.8% to NT$32.10. The fair value is estimated to be NT$24.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 44% over the last 3 years. Meanwhile, the company became loss making.New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (NT$1.17b market cap, or US$37.3m).New Risk • Jan 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (NT$1.41b market cap, or US$44.8m).New Risk • Aug 16New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (NT$1.65b market cap, or US$55.0m).Valuation Update With 7 Day Price Move • Aug 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$40.20, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 192% over the past three years.Valuation Update With 7 Day Price Move • Jul 12Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$58.50, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 326% over the past three years.Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$84.70, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 391% over the past three years.Upcoming Dividend • Jun 18Upcoming dividend of NT$1.50 per shareEligible shareholders must have bought the stock before 25 June 2025. Payment date: 08 August 2025. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 1.9%. Lower than top quartile of Taiwanese dividend payers (5.2%). Lower than average of industry peers (3.1%).New Risk • Apr 07New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 2.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (47% accrual ratio). Minor Risks High level of debt (71% net debt to equity). Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$2.65b market cap, or US$80.0m).Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to NT$61.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 221% over the past three years.Reported Earnings • Mar 25Full year 2024 earnings released: EPS: NT$5.39 (vs NT$1.70 loss in FY 2023)Full year 2024 results: EPS: NT$5.39 (up from NT$1.70 loss in FY 2023). Revenue: NT$1.18b (up 389% from FY 2023). Net income: NT$177.2m (up NT$232.6m from FY 2023). Profit margin: 15% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.お知らせ • Mar 17Sun Rise E&T Corporation, Annual General Meeting, Jun 04, 2025Sun Rise E&T Corporation, Annual General Meeting, Jun 04, 2025, at 10:00 Taipei Standard Time. Location: no,2, huan tung st. ta chou li, pingtung city TaiwanNew Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (NT$3.03b market cap, or US$92.0m).Valuation Update With 7 Day Price Move • Dec 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$101, the stock trades at a trailing P/E ratio of 55.9x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 306% over the past three years.New Risk • Dec 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (NT$3.18b market cap, or US$97.2m).New Risk • Nov 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$2.99b (US$91.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$2.99b market cap, or US$91.9m).Valuation Update With 7 Day Price Move • Nov 18Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to NT$90.70, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 304% over the past three years.New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (5.6% increase in shares outstanding).New Risk • Mar 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Earnings have declined by 54% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$100m (NT$1.83b market cap, or US$57.1m).New Risk • Feb 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (NT$1.87b market cap, or US$59.1m).Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$49.00, the stock trades at a trailing P/E ratio of 45.6x. Average trailing P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 124% over the past year.Reported Earnings • Aug 14First half 2023 earnings released: EPS: NT$0.16 (vs NT$0.032 in 1H 2022)First half 2023 results: EPS: NT$0.16 (up from NT$0.032 in 1H 2022). Revenue: NT$144.8m (up 2.9% from 1H 2022). Net income: NT$5.04m (up 409% from 1H 2022). Profit margin: 3.5% (up from 0.7% in 1H 2022).Reported Earnings • Apr 13Full year 2022 earnings released: EPS: NT$1.01 (vs NT$0.099 in FY 2021)Full year 2022 results: EPS: NT$1.01 (up from NT$0.099 in FY 2021). Revenue: NT$405.0m (up 48% from FY 2021). Net income: NT$30.9m (up NT$27.9m from FY 2021). Profit margin: 7.6% (up from 1.1% in FY 2021). The increase in margin was driven by higher revenue.Reported Earnings • Aug 15First half 2022 earnings released: EPS: NT$0.03 (vs NT$0.074 in 1H 2021)First half 2022 results: EPS: NT$0.03 (down from NT$0.074 in 1H 2021). Revenue: NT$140.7m (up 14% from 1H 2021). Net income: NT$991.0k (down 56% from 1H 2021). Profit margin: 0.7% (down from 1.8% in 1H 2021). The decrease in margin was driven by higher expenses.Reported Earnings • Apr 03Full year 2021 earnings released: EPS: NT$0.10 (vs NT$0.28 in FY 2020)Full year 2021 results: EPS: NT$0.10 (down from NT$0.28 in FY 2020). Revenue: NT$274.3m (up 20% from FY 2020). Net income: NT$3.01m (down 65% from FY 2020). Profit margin: 1.1% (down from 3.7% in FY 2020). The decrease in margin was driven by higher expenses.お知らせ • Apr 02Sun Rise E&T Corporation, Annual General Meeting, Jun 28, 2022Sun Rise E&T Corporation, Annual General Meeting, Jun 28, 2022.Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$22.55, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 15x in the Chemicals industry in Taiwan. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Sun Rise E&T は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測TPEX:1343 - アナリストの将来予測と過去の財務データ ( )TWD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2025471-80-153-123N/A9/30/2025644-45-294-73N/A6/30/2025817-9-436-22N/A3/31/202599684-310109N/A12/31/20241,175177-183239N/A9/30/2024882118-7224N/A6/30/202458959169208N/A3/31/2024415287119N/A12/31/2023240-55530N/A9/30/2023325-102456N/A6/30/2023409354381N/A3/31/2023407334783N/A12/31/2022405315185N/A9/30/2022348161035N/A6/30/20222922-32-16N/A3/31/20222832-1012N/A12/31/202127431139N/A9/30/202125762758N/A6/30/202123994277N/A3/31/202123491057N/A12/31/20202289-2236N/A9/30/202025210-2927N/A6/30/202027711-3617N/A3/31/202032424-3311N/A12/31/201937038-305N/A12/31/201859897N/A255N/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: 1343の予測収益成長が 貯蓄率 ( 1.3% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: 1343の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: 1343の収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: 1343の収益がTW市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: 1343の収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: 1343の 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/22 10:43終値2026/05/22 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Sun Rise E&T Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
Buy Or Sell Opportunity • May 04Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 32% to NT$20.60. The fair value is estimated to be NT$26.34, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Meanwhile, the company became loss making.
Buy Or Sell Opportunity • Apr 15Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 40% to NT$20.90. The fair value is estimated to be NT$26.31, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 28% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Apr 09Full year 2025 earnings released: NT$1.97 loss per share (vs NT$4.39 profit in FY 2024)Full year 2025 results: NT$1.97 loss per share (down from NT$4.39 profit in FY 2024). Revenue: NT$471.3m (down 60% from FY 2024). Net loss: NT$80.0m (down 145% from profit in FY 2024). Over the last 3 years on average, earnings per share has fallen by 14% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings.
お知らせ • Mar 23Sun Rise E&T Corporation, Annual General Meeting, Jun 17, 2026Sun Rise E&T Corporation, Annual General Meeting, Jun 17, 2026. Location: no,2, huan tung st. ta chou li, pingtung city Taiwan
Buy Or Sell Opportunity • Mar 02Now 30% overvaluedOver the last 90 days, the stock has fallen 8.8% to NT$32.10. The fair value is estimated to be NT$24.71, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has grown by 44% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2025. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Latest financial reports are more than 6 months old (reported June 2025 fiscal period end). Share price has been volatile over the past 3 months (8.1% average weekly change). Market cap is less than US$100m (NT$1.17b market cap, or US$37.3m).
New Risk • Jan 15New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 7.1% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.1% average weekly change). Market cap is less than US$100m (NT$1.41b market cap, or US$44.8m).
New Risk • Aug 16New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (NT$1.65b market cap, or US$55.0m).
Valuation Update With 7 Day Price Move • Aug 08Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to NT$40.20, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 21x in the Chemicals industry in Taiwan. Total returns to shareholders of 192% over the past three years.
Valuation Update With 7 Day Price Move • Jul 12Investor sentiment deteriorates as stock falls 20%After last week's 20% share price decline to NT$58.50, the stock trades at a trailing P/E ratio of 13.4x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 326% over the past three years.
Valuation Update With 7 Day Price Move • Jun 20Investor sentiment improves as stock rises 16%After last week's 16% share price gain to NT$84.70, the stock trades at a trailing P/E ratio of 15.7x. Average trailing P/E is 19x in the Chemicals industry in Taiwan. Total returns to shareholders of 391% over the past three years.
Upcoming Dividend • Jun 18Upcoming dividend of NT$1.50 per shareEligible shareholders must have bought the stock before 25 June 2025. Payment date: 08 August 2025. Payout ratio is a comfortable 28% but the company is not cash flow positive. Trailing yield: 1.9%. Lower than top quartile of Taiwanese dividend payers (5.2%). Lower than average of industry peers (3.1%).
New Risk • Apr 07New minor risk - Dividend sustainabilityThe dividend is not well covered by cash flows. The company is paying a dividend despite having no free cash flows. Dividend yield: 2.5% This is considered a minor risk. Dividends are ultimately paid out of the company's available cash reserves. Companies that pay out too much of their cash flow are at risk of having to reduce or cut their dividend in future. If cash flow growth slows or cash flows fall, then there may not be enough cash reserves to maintain the same dividend. Or in extreme cases, companies may opt to take on debt to maintain the dividend. This risk is mitigated by the fact the dividend is covered by earnings, however, cash flows are generally more important. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risk High level of non-cash earnings (47% accrual ratio). Minor Risks High level of debt (71% net debt to equity). Paying a dividend despite having no free cash flows. Market cap is less than US$100m (NT$2.65b market cap, or US$80.0m).
Valuation Update With 7 Day Price Move • Apr 07Investor sentiment deteriorates as stock falls 23%After last week's 23% share price decline to NT$61.00, the stock trades at a trailing P/E ratio of 11.3x. Average trailing P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 221% over the past three years.
Reported Earnings • Mar 25Full year 2024 earnings released: EPS: NT$5.39 (vs NT$1.70 loss in FY 2023)Full year 2024 results: EPS: NT$5.39 (up from NT$1.70 loss in FY 2023). Revenue: NT$1.18b (up 389% from FY 2023). Net income: NT$177.2m (up NT$232.6m from FY 2023). Profit margin: 15% (up from net loss in FY 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 83% per year but the company’s share price has only increased by 59% per year, which means it is significantly lagging earnings growth.
お知らせ • Mar 17Sun Rise E&T Corporation, Annual General Meeting, Jun 04, 2025Sun Rise E&T Corporation, Annual General Meeting, Jun 04, 2025, at 10:00 Taipei Standard Time. Location: no,2, huan tung st. ta chou li, pingtung city Taiwan
New Risk • Mar 02New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2024 fiscal period end). Market cap is less than US$100m (NT$3.03b market cap, or US$92.0m).
Valuation Update With 7 Day Price Move • Dec 26Investor sentiment improves as stock rises 18%After last week's 18% share price gain to NT$101, the stock trades at a trailing P/E ratio of 55.9x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 306% over the past three years.
New Risk • Dec 24New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of Taiwanese stocks, typically moving 6.2% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (6.2% average weekly change). Market cap is less than US$100m (NT$3.18b market cap, or US$97.2m).
New Risk • Nov 18New minor risk - Market cap sizeThe company's market capitalization is less than US$100m. Market cap: NT$2.99b (US$91.9m) This is considered a minor risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Market cap is less than US$100m (NT$2.99b market cap, or US$91.9m).
Valuation Update With 7 Day Price Move • Nov 18Investor sentiment deteriorates as stock falls 16%After last week's 16% share price decline to NT$90.70, the stock trades at a trailing P/E ratio of 50.5x. Average trailing P/E is 22x in the Chemicals industry in Taiwan. Total returns to shareholders of 304% over the past three years.
New Risk • Sep 08New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 5.6% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.5% average weekly change). Earnings have declined by 9.4% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (5.6% increase in shares outstanding).
New Risk • Mar 29New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Earnings have declined by 54% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.3% average weekly change). Market cap is less than US$100m (NT$1.83b market cap, or US$57.1m).
New Risk • Feb 27New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended June 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 35% per year over the past 5 years. Minor Risks Latest financial reports are more than 6 months old (reported June 2023 fiscal period end). Share price has been volatile over the past 3 months (6.9% average weekly change). Market cap is less than US$100m (NT$1.87b market cap, or US$59.1m).
Valuation Update With 7 Day Price Move • Jan 23Investor sentiment improves as stock rises 19%After last week's 19% share price gain to NT$49.00, the stock trades at a trailing P/E ratio of 45.6x. Average trailing P/E is 20x in the Chemicals industry in Taiwan. Total returns to shareholders of 124% over the past year.
Reported Earnings • Aug 14First half 2023 earnings released: EPS: NT$0.16 (vs NT$0.032 in 1H 2022)First half 2023 results: EPS: NT$0.16 (up from NT$0.032 in 1H 2022). Revenue: NT$144.8m (up 2.9% from 1H 2022). Net income: NT$5.04m (up 409% from 1H 2022). Profit margin: 3.5% (up from 0.7% in 1H 2022).
Reported Earnings • Apr 13Full year 2022 earnings released: EPS: NT$1.01 (vs NT$0.099 in FY 2021)Full year 2022 results: EPS: NT$1.01 (up from NT$0.099 in FY 2021). Revenue: NT$405.0m (up 48% from FY 2021). Net income: NT$30.9m (up NT$27.9m from FY 2021). Profit margin: 7.6% (up from 1.1% in FY 2021). The increase in margin was driven by higher revenue.
Reported Earnings • Aug 15First half 2022 earnings released: EPS: NT$0.03 (vs NT$0.074 in 1H 2021)First half 2022 results: EPS: NT$0.03 (down from NT$0.074 in 1H 2021). Revenue: NT$140.7m (up 14% from 1H 2021). Net income: NT$991.0k (down 56% from 1H 2021). Profit margin: 0.7% (down from 1.8% in 1H 2021). The decrease in margin was driven by higher expenses.
Reported Earnings • Apr 03Full year 2021 earnings released: EPS: NT$0.10 (vs NT$0.28 in FY 2020)Full year 2021 results: EPS: NT$0.10 (down from NT$0.28 in FY 2020). Revenue: NT$274.3m (up 20% from FY 2020). Net income: NT$3.01m (down 65% from FY 2020). Profit margin: 1.1% (down from 3.7% in FY 2020). The decrease in margin was driven by higher expenses.
お知らせ • Apr 02Sun Rise E&T Corporation, Annual General Meeting, Jun 28, 2022Sun Rise E&T Corporation, Annual General Meeting, Jun 28, 2022.
Valuation Update With 7 Day Price Move • Aug 19Investor sentiment improved over the past weekAfter last week's 15% share price gain to NT$22.55, the stock trades at a trailing P/E ratio of 79.7x. Average trailing P/E is 15x in the Chemicals industry in Taiwan.